[Helicobacter pylori infection as additional risk factor of the development of NSAID-gastropatia effects at the patients with osteoarthritis].
Prevalence of osteoartrosis disease is high among the population. The main places in treatment of this pathology occupy NSAID. Intake of NSAID is lead to the development of NSAID-gastropatia. During last years H. pylori infection was numbered with risk factors of the NSAID-gastropatia development. In this review considered researches which are devoted to studying ties between H. pylori and NSAID. Data of the using eradication therapy with purpose of prevention and treatment of NSAID-gastropatia associated with H. pylori are shown in this review.
Maev
I V
IV
Samsonov
A A
AA
Lezhneva
Iu A
IuA
Andreev
N G
NG
Salova
L M
LM
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D016481:Helicobacter Infections / Q000139:chemically induced / Q000628:therapy; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D010003:Osteoarthritis / Q000188:drug therapy*; D012307:Risk Factors; D013272:Stomach Diseases / Q000139:chemically induced / Q000628:therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal